You are here: Industry Insights > U.K.

News List

Ionis' Tegsedi gets a U.K. boost after NICE reverses initial guidance fiercepharma
April 18, 2019
The path for Ionis’ Tegsedi in the U.K. looked rocky after a preliminary “no” last year from England's drug-price watchdog.
UCB to spend £200M to create U.K. R&D hub fiercebiotech
January 02, 2019
UCB is set to spend up to £200 million ($255 million) to create a new R&D facility in the U.K. The British government unveiled UCB’s investment in its second life science sector deal, which disclosed total spending of £1.3 billion.....
U.K. sets out digital, data-driven plan to accelerate R&D fiercebiotech
January 02, 2019
The U.K. government has set out how it plans to use data and digital technologies to attract clinical trials. Near-term plans include the creation of a system for assessing study feasibility and an app to connect patients to studies.....
Officials deny shortage of Seqirus' Fluad in the U.K. as season nears fiercepharma
October 18, 2018
As pharmacists in the U.K. reportedly turn seniors away from receiving Seqirus' Fluad because of short supplies, company officials say there isn't a shortage. Instead, they say, deliveries will be staggered over several months in ...
U.K. court invalidates Gilead's Truvada patent extension, allowing PrEP generics fiercepharma
September 21, 2018
Activists in the U.S. are asking authorities to break Gilead’s patents on Truvada in an effort to help end the HIV epidemic. Now, a court in the U.K. has done just that, potentially allowing for widespread use of generics as a ...
U.K. to offer Merck's Gardasil to boys after years of protests fiercepharma
July 25, 2018
Based on a recommendation from the Joint Committee on Vaccination and Immunisation (JCVI), the U.K. government announced on Tuesday that the vaccine will be offered to boys aged 12 and 13 in an effort to protect them against several types of cancer caused
U.K. votes to ‘fully participate’ in EMA after Brexit biospectrumasia
July 23, 2018
British politicians have voted for the U.K. to try to remain close to the EMA after Brexit.
Trump’s U.K. visit sparks plans for mass protests—and dinner invites for GSK, J&J CEOs fiercepharma
July 06, 2018
But some business leaders say they’re skeptical the gathering will go forward, according to the report.